www.prnewswire.com SEOUL, South Korea, Oct. 25, 2022 /PRNewswire/ — SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe, today announced that the Company made a new partnership agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of mRNA vaccines to quickly respond to the spread of infectious diseases and to expand its vaccine portfolio.
Richard Hatchett, CEO of CEPI, Park Min-soo, Second Vice Minister of the Ministry of Health and Welfare (MOHW), Chang Won (Andrew) Chey, Vice Chairman of SK discovery, and Jaeyong Ahn, CEO of SK bioscience attended the signing ceremony at Grand Walkerhill Seoul and discussed continuous cooperation between the two organizations for the development of mRNA vaccines.
Read Full Article Here…(prnewswire.com)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
